210 related articles for article (PubMed ID: 27624076)
1. Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors.
Okuda M; Hijikuro I; Fujita Y; Teruya T; Kawakami H; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2016 Oct; 26(20):5024-5028. PubMed ID: 27624076
[TBL] [Abstract][Full Text] [Related]
2. PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.
Okuda M; Fujita Y; Hijikuro I; Wada M; Uemura T; Kobayashi Y; Waku T; Tanaka N; Nishimoto T; Izumi Y; Kume T; Akaike A; Takahashi T; Sugimoto H
J Alzheimers Dis; 2017; 59(1):313-328. PubMed ID: 28598836
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review.
Malafaia D; Albuquerque HMT; Silva AMS
Eur J Med Chem; 2021 Mar; 214():113209. PubMed ID: 33548635
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Novel Curcumin Derivatives as Potent Inhibitors of Inflammation and Amyloid-β Aggregation in Alzheimer's Disease.
Lakey-Beitia J; González Y; Doens D; Stephens DE; Santamaría R; Murillo E; Gutiérrez M; Fernández PL; Rao KS; Larionov OV; Durant-Archibold AA
J Alzheimers Dis; 2017; 60(s1):S59-S68. PubMed ID: 28453488
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
Chen SY; Chen Y; Li YP; Chen SH; Tan JH; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Sep; 19(18):5596-604. PubMed ID: 21840724
[TBL] [Abstract][Full Text] [Related]
6. Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation.
Son SH; Do JM; Yoo JN; Lee HW; Kim NK; Yoo HS; Gee MS; Kim JH; Seong JH; Inn KS; Seo MD; Lee JK; Kim NJ
Bioorg Chem; 2021 Aug; 113():105022. PubMed ID: 34098397
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation.
Lv P; Xia CL; Wang N; Liu ZQ; Huang ZS; Huang SL
Bioorg Med Chem; 2018 Sep; 26(16):4693-4705. PubMed ID: 30107970
[TBL] [Abstract][Full Text] [Related]
8. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
[TBL] [Abstract][Full Text] [Related]
9. "Clicked" sugar-curcumin conjugate: modulator of amyloid-β and tau peptide aggregation at ultralow concentrations.
Dolai S; Shi W; Corbo C; Sun C; Averick S; Obeysekera D; Farid M; Alonso A; Banerjee P; Raja K
ACS Chem Neurosci; 2011 Dec; 2(12):694-9. PubMed ID: 22860163
[TBL] [Abstract][Full Text] [Related]
10. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging.
Ryu EK; Choe YS; Lee KH; Choi Y; Kim BT
J Med Chem; 2006 Oct; 49(20):6111-9. PubMed ID: 17004725
[TBL] [Abstract][Full Text] [Related]
11. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation.
Park SY; Kim HS; Cho EK; Kwon BY; Phark S; Hwang KW; Sul D
Food Chem Toxicol; 2008 Aug; 46(8):2881-7. PubMed ID: 18573304
[TBL] [Abstract][Full Text] [Related]
12. Structure activity relationship study of curcumin analogues toward the amyloid-beta aggregation inhibitor.
Endo H; Nikaido Y; Nakadate M; Ise S; Konno H
Bioorg Med Chem Lett; 2014 Dec; 24(24):5621-5626. PubMed ID: 25467149
[TBL] [Abstract][Full Text] [Related]
13. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
14. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Derivative GT863 Inhibits Amyloid-Beta Production via Inhibition of Protein N-Glycosylation.
Urano Y; Takahachi M; Higashiura R; Fujiwara H; Funamoto S; Imai S; Futai E; Okuda M; Sugimoto H; Noguchi N
Cells; 2020 Feb; 9(2):. PubMed ID: 32028683
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Scaffold as a Multifunctional Tool for Alzheimer's Disease Research.
Yang H; Zeng F; Luo Y; Zheng C; Ran C; Yang J
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745002
[TBL] [Abstract][Full Text] [Related]
17. Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice.
Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Hirao K; Shirai N; Sogabe T; Tooyama I
Neurobiol Aging; 2015 Jan; 36(1):201-10. PubMed ID: 25179227
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of Alzheimer's disease: the long and filamentous road.
Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
